Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| UG3HL165019 | U.S. NIH Grant/Contract | View source | |
| U24HL165014 | U.S. NIH Grant/Contract | View source | |
| UH3HL165019 | U.S. NIH Grant/Contract | View source | |
| R01HL181356 | U.S. NIH Grant/Contract | View source |
Not provided
Not provided
Enrollment in Stage I paused due to operational futility.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| National Heart, Lung, and Blood Institute (NHLBI) | NIH |
| University of Utah | OTHER |
Not provided
Not provided
Not provided
Not provided
This study is a Phase 3, multi-center, Bayesian Adaptive Sequential Platform Trial testing the effectiveness of different prehospital airway management strategies in the care of critically ill children. Emergency Medical Services (EMS) agencies affiliated with the Pediatric Emergency Care Applied Research Network (PECARN) will participate in the trial. The study interventions are strategies of prehospital airway management: [BVM-only], [BVM followed by SGA] and [BVM followed by ETI]. The primary outcome is 30-day ICU-free survival. The trial will be organized and executed in two successive stages. In Stage I of the trial, EMS personnel will alternate between two strategies: [BVM-only] or [BVM followed by SGA]. The [winner of Stage I] will advance to Stage II based upon results of Bayesian interim analyses. In Stage II of the trial, EMS personnel will alternate between [BVM followed by ETI] vs. [Winner of Stage I].
Cardiac arrest, respiratory failure, and major trauma are devastating critical conditions in children. Resuscitation from critical illness requires skillful airway management to optimize the delivery of oxygen to the lungs, preventing irreparable damage to the brain and heart. As the first to provide resuscitation care for critically ill children, prehospital EMS personnel are often the first to perform life-saving airway management.
The most common prehospital airway management techniques (bag-valve-mask ventilation [BVM], endotracheal intubation [ETI], and supraglottic airway insertion [SGA]) have important trade-offs between risks and benefits. Despite the challenges of ETI and national recommendations favoring BVM, many EMS personnel favor ETI over BVM. Newer SGA devices such as the laryngeal tube (LT), laryngeal mask airway (LMA), and i-gel® have not been compared with other techniques in children. National organizations, including the Agency for Healthcare Research and Quality, have declared the need for new, rigorous trials of all techniques to determine the best strategies for prehospital airway management in children. Interviews with front-line EMS personnel underscore the dire need for clear and strategic guidelines for managing the pediatric airway.
The Pediatric Prehospital Airway Resuscitation Trial (Pedi-PART) will determine the best strategies for prehospital airway management in critically ill children. The trial aims are Aim I-Primary Objective (Effectiveness)-Stage I: Determine if [BVM-only] or [BVM followed by SGA] results in better ICU-free survival in critically ill children with cardiac arrest, major trauma, or respiratory failure. Stage II: Determine if [winner of Stage I] or [BVM followed by ETI] results in better ICU-free survival. Bayesian analyses will determine the transition from Stage I to Stage II, ensuring optimal deployment of available subjects to address the postulated questions. Aim 2- Secondary Objective (Safety)-Stage I: Determine if [BVM followed by SGA] results in fewer prehospital and hospital safety events compared with [BVM-only] in critically ill children with cardiac arrest, major trauma, or respiratory failure. Stage II: Determine if the winner of Stage I results in fewer safety events compared with [BVM followed by ETI].
The trial will use a Bayesian Adaptive Sequential Comparison Platform Trial (BASiC-PT) design and will be executed in two sequential stages. Stage I: Determine if [BVM-only] or [BVM followed by SGA] results in better ICU-free survival in critically ill children with cardiac arrest, major trauma, or respiratory failure. Stage II: Determine if [winner of Stage I] or [BVM followed by ETI] results in better ICU-free survival. Bayesian analyses will determine the transition from Stage I to Stage II, ensuring optimal deployment of available subjects to address the postulated questions.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| BVM-only | Active Comparator | Initial strategy of airway management using Bag-Valve-Mask (BVM) only. |
|
| BVM followed by SGA [BVM+SGA] | Active Comparator | Initial strategy of airway management using Bag-Valve-Mask (BVM) followed by Supraglottic Airway (SGA). |
|
| BVM followed by ETI [BVM+ETI] | Active Comparator | Initial strategy of airway management using Bag-Valve-Mask (BVM) followed by Endotracheal Intubation (ETI). |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| BVM | Device | Bag-Valve-Mask Ventilation |
|
| Measure | Description | Time Frame |
|---|---|---|
| 30-day ICU-free survival | The number of days in the first 30 days after the treatment event where: 1) the patient was not known to have died; and 2) the patient was not hospitalized in the intensive care unit. ICU admission/discharge criteria will not be standardized. | 30 days |
| Measure | Description | Time Frame |
|---|---|---|
| Neurologic outcome upon hospital discharge | Outcome will be measured with Pediatric Cerebral Performance Category score (PCPC - 1 = normal, 2 = mild disability, 3 = moderate disability, 4 = severe disability, 5 = coma or vegetative state, 6 = dead). | Identified through end of study but no later than 30 days after final enrollment. |
Not provided
Inclusion criteria are:
Exclusion criteria are:
EMS personnel will use bystander reports or follow local protocols to establish patient age and pregnancy status.
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Henry E Wang, MD, MS | Ohio State University | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| University of Airzona | Tucson | Arizona | 85721 | United States | ||
| Harbor-University of California Los Angeles Medical Center |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 34875893 | Background | Bosson N, Hansen M, Gausche-Hill M, Lewis RJ, Wendelberger B, Shah MI, VanBuren JM, Wang HE. Design of a novel clinical trial of prehospital pediatric airway management. Clin Trials. 2022 Feb;19(1):62-70. doi: 10.1177/17407745211059855. Epub 2021 Dec 7. |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The trial uses a Bayesian Adaptive Sequential Platform Trial (BASIC-PT) framework.
The study interventions are strategies of prehospital airway management: [BVM-only], [BVM followed by SGA] and [BVM followed by ETI].
The trial will be organized and executed in two successive stages. In Stage I of the trial, EMS personnel will alternate between two strategies: [BVM-only] or [BVM followed by SGA]. The [winner of Stage I] will advance to Stage II based upon results of Bayesian interim analyses. In Stage II of the trial, EMS personnel will alternate between [BVM followed by ETI] vs. [Winner of Stage I].
The interventions will be quasi-randomized using alternate day assignment.
Not provided
Not provided
Not provided
Not provided
| SGA | Device | Supraglottic Airway |
|
| ETI | Device | Endotracheal Intubation |
|
| Los Angeles |
| California |
| 90509 |
| United States |
| University of California Davis | Sacramento | California | 95817 | United States |
| University of Colordao | Aurora | Colorado | 80045 | United States |
| Children's National Hospital | Washington D.C. | District of Columbia | 20010 | United States |
| Indiana University | Indianapolis | Indiana | 46202 | United States |
| Mecklenburg County Emergency Medical Services | Charlotte | North Carolina | 28208 | United States |
| Nationwide Children's Hospital | Columbus | Ohio | 43205 | United States |
| Dell Medical School, University of Texas at Austin | Austin | Texas | 78712 | United States |
| Medical College of Wisconsin | Milwaukee | Wisconsin | 53226 | United States |
| ID | Term |
|---|---|
| D058687 | Out-of-Hospital Cardiac Arrest |
| D014947 | Wounds and Injuries |
| D016638 | Critical Illness |
| D006323 | Heart Arrest |
| D012131 | Respiratory Insufficiency |
| ID | Term |
|---|---|
| D006331 | Heart Diseases |
| D002318 | Cardiovascular Diseases |
| D020969 | Disease Attributes |
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D012120 | Respiration Disorders |
| D012140 | Respiratory Tract Diseases |
Not provided
Not provided